Veronika Alberg

Field of research

  • Physiologically based pharmacokinetic (PBPK) modeling

Curriculum vitae

Since 11/2024: Doctoral student Clinical Pharmacy, Saarland University, Saarbrücken

10/2023 – 11/2024: Master studentClinical Pharmacy, Saarland University, Saarbrücken

06/2023: Licensed as pharmacist

11/2022 – 04/2023: Practical year, Apotheke Feudenheim, Mannheim

05/2022 – 10/2022: Practical year, InfectoPharm Arzneimittel und Consilium GmbH, Heppenheim

11/2021 – 04/2022: Practical year, Roche, Mannheim

10/2017 – 09/2021: Pharmacy studies, Saarland University, Saarbrücken

06/2017: Abitur, Marie Luise-Kaschnitz-Gymnasium, Völklingen

Publications

Manuscripts

Lehr T, Meiser P, Selzer D, Rixecker T, Holzer F, Mösges R, Smola S, Bals R, CONTAIN Study Group. Azelastine nasal spray for prevention of SARS-CoV-2 infections: A phase 2 randomized clinical trial. JAMA Intern Med. 2025.doi:10.1001/jamainternmed.2025.4283

 

Awards

Posterpreis. PhD Students' Day, 2025, Saarbrücken, Germany.            

Contact information

Veronika Alberg

Clinical Pharmacy
Saarland University
Campus C4 1, Room -1.09
66123 Saarbrücken

T: +49/681/302-70257
F: +49/681/302-70258

veronika.alberg(at)uni-saarland.de